Title Date
Dako Announces FDA Approval of New Test for Lung Cancer PatientsOct 12, 2015
Dako Announces FDA Approval of New Companion Diagnostic for Lung CancerOct 05, 2015
Resolution to U.S. FDA Warning Letter for Dako DenmarkApr 22, 2015
Dako announces expanded collaboration with Amgen within companion diagnosticsMar 24, 2015
Dako and ONO PHARMACEUTICAL CO., LTD. announce collaboration on development of PD-L1 companion diagnostic testFeb 16, 2015
Dako and Cell Signaling Technology announce partnership within companion diagnosticsJan 12, 2015
Dako Launches Fast HER2 ISH Assay for New Automated Staining Platform in EuropeSep 01, 2014
Dako Sponsors European Pathology Congress for Second Straight YearAug 29, 2014
Dako Sponsors Largest Histology Congress for 34th Year in a RowAug 25, 2014
New White Paper by ProPath Supports Superiority of Dako’s HER2 IQFISH pharmDxTM KitJul 07, 2014
Dako partners with Euro Diagnostica on Chromogranin A ELISA KitJun 02, 2014
Dako and U.S.-based Merck & Co. to collaborate on companion diagnostic test for analysis of tumor PD-L1 levelsMay 30, 2014
Dako, an Agilent Technologies Company, Launches Two Ready-to-Use Antibodies for Cancer DiagnosisMay 02, 2014
Dako Collaborates on Review of Immunohistochemistry’s Impact on Prostate DiagnosticsMar 05, 2014
Dako White Paper Outlines High-Quality Staining Enabled by Its New Immunohistochemical Staining PrincipleMar 04, 2014
Dako is Official Platinum Sponsor of Global Pathology Congress for Second Straight YearMar 03, 2014
Dako further expands world’s leading special stain solution for cancer diagnosticsFeb 28, 2014
New Study Reinforces Major Advantages of Dako’s HER2 IQFISH pharmDx™ in Breast Cancer DiagnosticsFeb 14, 2014
Dako and Amgen expand collaborationFeb 11, 2014
Dako to collaborate with Merck on development of companion diagnostics for cancer treatmentJan 09, 2014
Dako Publishes Sixth Edition of Immunohistochemistry GuidebookDec 12, 2013
Dako and Omnyx, LLC Launch Digital Pathology Solution for Breast Cancer Diagnostics Aug 30, 2013
Dako to Offer New Antibody in U.S. to Diagnose Breast CancerApr 03, 2013
FDA Approves Two Dako Assays as Companion Diagnostics for Genentech’s New Breast Cancer Medicine KadcylaMar 05, 2013
Dako Launches Advanced Staining Platform at Global Pathology CongressMar 04, 2013
Dako Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer DiagnosticsFeb 15, 2013
Dako to Collaborate with Pfizer on Companion DiagnosticsFeb 12, 2013
Dako enters collaboration with Eli Lilly and CompanyJan 07, 2013

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.

Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement

Get in Touch with Dako in Austria

  • Pathology Products
    Dako Österreich GmbH
    +43 1360 2771 213
    +43 1253 6722 4966

    Mooslackengasse 17
    A-1190 Wien

  • Flow Cytometry Products and Specific Proteins
    Szabo-Scandic HandelsgmbH & Co KG
    +43-1-489 3961-0
    +43-1-489 3961-7

    Quellenstraße 110
    1100 Wien

Detailed contact information

Submit an Inquiry

How would you like us to follow up?

Your session expired

You have been logged out. Log in again to retrieve your Cart.